Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
atrial flutter/oksendamine
Link salvestatakse lõikelauale
Leht 1 alates 22 tulemused
A randomized clinical trial of continuous flow nitrous oxide and nalbuphine infusion for sedation of patients during radiofrequency atrial flutter ablation.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
In patients with common atrial flutter (CAF), radiofrequency ablation (RFA) causes discomfort. Patients undergoing RFA often feel pain which is difficult to control as the mechanisms are unclear.
OBJECTIVE
Inhaled nitrous oxide (N2O) is a potent sedative-analgesic-anxiolytic agent that
Splenic rupture following synchronised direct current cardioversion.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Atraumatic rupture of the normal spleen is a rare entity. Often, a triggering factor or minor physical event can be ascribed as the aetiology for rupture, including coughing, vomiting or minor medical procedures not involving the spleen. A 65-year-old man who was hospitalised for eosinophilic
Multiple cardiac arrhythmias in a previously healthy child: a case of accidental digitalis intoxication?
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We present a case of multiple arrhythmias in a 3-year-old child who was presented to the emergency department with emesis. Initial vital signs were significant for a heart rate from 40 to 60 beats per minute with stable blood pressure. An electrocardiogram showed complete atrioventricular block with
A Dieulafoy's lesion in a duodenal diverticulum. An infrequent cause of UGIB.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We present the case of an 82-year-old man with a history of heart failure, mitral regurgitation, type 2 DM, hypertension, dilated cardiomyopathy and a paroxysmal atrial flutter. The patient was under treatment with Sintrom. The patient presented to the emergency department due to melenic depositions
Thyrotoxic Periodic Paralysis and Cardiomyopathy in a Patient with Graves' Disease.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Thyrotoxic periodic paralysis (TPP) and cardiomyopathy are two established complications of thyrotoxicosis. Emergent management is essential as TPP and cardiac events secondary to thyrotoxic cardiomyopathy can be fatal. We report a unique case of a patient with Graves' disease presenting with
Dronedarone: a new antiarrhythmic agent.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Dronedarone is an antiarrhythmic agent recently approved by the United States Food and Drug Administration for the reduction of cardiovascular-related hospitalizations in patients with paroxysmal or persistent atrial fibrillation or atrial flutter. The drug is a derivative of amiodarone and has been
A case report of absolute thrombocytopenia with ticagrelor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background: We report a rare case of absolute thrombocytopenia with ticagrelor after 6 h of single loading dose of ticagrelor.
Case summary: A 68-year-old male with ischaemic
E 047/1: a new class III antiarrhythmic agent.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The efficacy, pharmacokinetics, safety, and tolerability of E 047/1, an amiodarone derivative, were evaluated in patients with acute supraventricular or ventricular arrhythmia. In an open, nonrandomized prospective multicenter trial, 20 patients were treated with three different i.v. dosage regimens
[Treatment of atrial fibrillation using intravenous infusion of quinidine].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Quinidine gluconate was administered slowly by intravenous infusion to 20 patients with atrial fibrillation. Nineteen of them had rheumatic heart disease and the other one had Ebstein's disease. The first ten patients received 0.027 mg/kg/min during 6 hs or less if they returned to normal sinus
Propofol for direct current cardioversion in cardiac risk patients.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We investigated 69 patients (most belonging to NYHA classes II and III) undergoing elective direct current cardioversion of atrial fibrillation (46 patients) and atrial flutter (23 patients), respectively. Without premedication anaesthesia was induced with the new soya bean emulsion of propofol
Superior mesenteric artery thrombosis after abrupt discontinuation of rivaroxaban.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We report a case of superior mesenteric artery thrombosis after the abrupt discontinuation of rivaroxaban in a 59-year-old male patient. The initial presentation was of sudden onset abdominal pain, nausea, vomiting, diarrhea, and hematochezia in the setting of recently holding rivaroxaban
Clinical implications of differences in pharmacodynamic action of polar and nonpolar cardiac glycosides.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The principal effects of cardiac glycosides probably can be classified as parasympathomimetic or sympathomimetic. Data from animals and from man suggest that polar cardiac glycosides, such as ouabain and digoxin, possess greater parasympathomimetic (vagal) cardiac effect for a given amount of
Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Aclacinomycin A (ACM) was administered for induction treatment to 40 previously treated acute myeloid leukemia (AML) patients. 38 patients aged 2 to 80 years (mean +/- SE, 35.0 +/- 3.2 years) with overt AML were evaluated; of these, seventeen patients were given ACM after an unsuccessful attempt to
Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Aclarubicin (ACM) was administered as induction treatment to 40 patients with acute myeloid leukemia (AML) who were either refractory to initial induction chemotherapy or in relapse. Thirty-eight patients with AML, 2-80 years of age (mean +/- SE, 35.0 +/- 3.2), were evaluated during this study.
Pyogenic liver abscess: uncommon presentation.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Pyogenic liver abscess is a rare entity, but it is fatal when untreated. With a peak incidence in the fifth decade of life, its early recognition and intervention are key to successful treatment and better prognosis of patients. In recent years, its approach has been enhanced by the use of
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
